- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 1.77B sh |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $1.59B |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $1M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $31M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $5.18B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $5.52B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $1.42B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $3.33B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $36.4B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $38.75B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $27.68B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $25.58B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $136.17B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $135.16B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 1.77B sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $1.32B |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $2.77B |
| Capex | Q1 2025 · Mar 31, 2024 | $193M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $4.04B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.77 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.77 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $3.32B |
| Net Income | Q1 2025 · Mar 31, 2024 | $1.37B |
| Operating Income | Q1 2025 · Mar 31, 2024 | $2.8B |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $4.09B |